Journal of Immunoassay · 1995 · 10 citations · 16 references
PharmacyBiochemistryBiosensorsChromatographic AnalysisImmunotechnologyBioanalytical ChemistryBioanalytical Method ValidationChromatographyChromatography CouplingConjugation ReactionsLiquid ChromatographyBioanalytical ChromatographyChemical Stability AssessmentChemical Stability TestingCompetitive Immunoassay DesignCyclic Guanosine Monophosphate PathwayImmunoassay MethodologyReversed-phase ChromatographyReversed-phase Liquid Chromatography
2'-O-monosuccinylguanosine 3':5'-cyclic monophosphate was coupled to N-biotinyl-1,8-diamino-3,6-dioxaoctane after converting succinyl-cGMP into its N-hydroxysuccinimide active ester. Isolation and purification of the succinyl-cGMP-biotin conjugate was performed with FPLC using reversed phase chromatography. The synthesis described yielded a conjugate suitable for use as tracer in immunoassays for the cGMP measurement in plasma and urine samples. Employing biotin as the primary probe in a competitive solid phase immunoassay allows for flexible end point determination by means of commercially available labeled streptavidin derivatives. Streptavidin-europium was used in conjunction with the DELFIA-system for time-resolved fluorometric end point measurement (TR-FIA), streptavidin-horseradish peroxidase was used for colorimetric end point determination (EIA). Both non radioactive immunoassay systems showed excellent correlation with the reference radioimmunoassay, good sensitivity and reproducibility. The succinyl-cGMP-biotin conjugate was shown to be stable for more than two years without any apparent loss of chemical stability or immunological reactivity.
16
Regina Dressendörfer, Clemens Kirschbaum, W. Rohde et al. · The Journal of Steroid Biochemistry and Molecular Biology · 1992 · 892 citations